Published in Medical Device Law Weekly, December 14th, 2008
Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, and Shreya Life Sciences Pvt. Ltd. (www.shreya.co.in), the Company's importation, marketing and distribution licensee in India and the fourth largest marketer of insulin in India, jointly announced the launch of commercial retail sales of Generex Oral-lyn(tm) in India. Generex Oral-lyn is approved in India for the treatment of adults and children with Type 1 and Type 2 diabetes and will be marketed and sold in India under the brand...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.